找到约 4 条结果
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer in CheckMate 227
DISCLAIMER: This is a PDF file of an unedited manuscript that has been accepted for publication. As aservice to our subscribers we are providing this early version of the article. The paper will be copy editedand typeset.....
医客学院
关注公众号
安卓客户端
